471 related articles for article (PubMed ID: 33581873)
1. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
Slosky LM; Caron MG; Barak LS
Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873
[TBL] [Abstract][Full Text] [Related]
2. Allosteric modulation of G protein-coupled receptor signaling.
Shen S; Zhao C; Wu C; Sun S; Li Z; Yan W; Shao Z
Front Endocrinol (Lausanne); 2023; 14():1137604. PubMed ID: 36875468
[TBL] [Abstract][Full Text] [Related]
3. GPCR Allosteric Modulator Discovery.
Wu Y; Tong J; Ding K; Zhou Q; Zhao S
Adv Exp Med Biol; 2019; 1163():225-251. PubMed ID: 31707706
[TBL] [Abstract][Full Text] [Related]
4. Allosteric coupling and biased agonism in G protein-coupled receptors.
Bock A; Bermudez M
FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discovery.
Zhang M; Lan X; Li X; Lu S
Drug Discov Today; 2023 Dec; 28(12):103803. PubMed ID: 37852356
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
7. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
Persechino M; Hedderich JB; Kolb P; Hilger D
Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
10. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
[TBL] [Abstract][Full Text] [Related]
11. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.
Zhang M; Chen T; Lu X; Lan X; Chen Z; Lu S
Signal Transduct Target Ther; 2024 Apr; 9(1):88. PubMed ID: 38594257
[TBL] [Abstract][Full Text] [Related]
12. Regulation of G protein-coupled receptors by allosteric ligands.
Lane JR; Abdul-Ridha A; Canals M
ACS Chem Neurosci; 2013 Apr; 4(4):527-34. PubMed ID: 23398684
[TBL] [Abstract][Full Text] [Related]
13. In Silico Study of Allosteric Communication Networks in GPCR Signaling Bias.
Morales-Pastor A; Nerín-Fonz F; Aranda-García D; Dieguez-Eceolaza M; Medel-Lacruz B; Torrens-Fontanals M; Peralta-García A; Selent J
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887157
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
Reinecke BA; Wang H; Zhang Y
Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
[TBL] [Abstract][Full Text] [Related]
15. Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery.
Bian Y; Jun JJ; Cuyler J; Xie XQ
Eur J Med Chem; 2020 Nov; 206():112690. PubMed ID: 32818870
[TBL] [Abstract][Full Text] [Related]
16. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain.
Felder CC
Adv Pharmacol; 2019; 86():1-20. PubMed ID: 31378249
[TBL] [Abstract][Full Text] [Related]
17. Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.
Luttrell LM
Mol Endocrinol; 2014 Mar; 28(3):281-94. PubMed ID: 24433041
[TBL] [Abstract][Full Text] [Related]
18. Allosteric modulation of G protein-coupled receptors.
May LT; Avlani VA; Sexton PM; Christopoulos A
Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
[TBL] [Abstract][Full Text] [Related]
19. Emerging paradigms in GPCR allostery: implications for drug discovery.
Wootten D; Christopoulos A; Sexton PM
Nat Rev Drug Discov; 2013 Aug; 12(8):630-44. PubMed ID: 23903222
[TBL] [Abstract][Full Text] [Related]
20. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
